Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d.

Markovic D, Lehnert H, Levine MA, Grammatopoulos DK.

Mol Endocrinol. 2008 Nov;22(11):2505-19. doi: 10.1210/me.2008-0177. Epub 2008 Sep 4.

PMID:
18772229
2.

Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction.

Grammatopoulos DK.

Br J Pharmacol. 2012 May;166(1):85-97. doi: 10.1111/j.1476-5381.2011.01631.x. Review.

3.

Corticotropin releasing hormone and the skin.

Slominski A, Zbytek B, Zmijewski M, Slominski RM, Kauser S, Wortsman J, Tobin DJ.

Front Biosci. 2006 Sep 1;11:2230-48. Review.

4.
5.

Multiple sites of control of type-1 corticotropin releasing hormone receptor levels in the pituitary.

Nikodemova M, Diehl CR, Aguilera G.

Arch Physiol Biochem. 2002 Apr;110(1-2):123-8. Review.

PMID:
11935409
6.
7.

Corticotropin-releasing hormone-related peptides and receptors: emergent regulators of cardiovascular adaptations to stress.

Coste SC, Quintos RF, Stenzel-Poore MP.

Trends Cardiovasc Med. 2002 May;12(4):176-82. Review.

PMID:
12069758
8.

Corticotropin releasing factor receptors and their ligand family.

Perrin MH, Vale WW.

Ann N Y Acad Sci. 1999 Oct 20;885:312-28. Review.

PMID:
10816663
9.

The role of urocortins in the cardiovascular system.

Walczewska J, Dzieza-Grudnik A, Siga O, Grodzicki T.

J Physiol Pharmacol. 2014 Dec;65(6):753-66. Review.

10.

Targeting antibodies to the cytoplasm.

Marschall AL, Frenzel A, Schirrmann T, Schüngel M, Dübel S.

MAbs. 2011 Jan-Feb;3(1):3-16. Epub 2011 Jan 1. Review.

Supplemental Content

Support Center